^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

teverelix LA (ARD-03)

i
Other names: ARD-03, EP-24332, EP 24332
Associations
Trials
Company:
Ardana Biosci
Drug class:
GnRH antagonist
Associations
Trials
over4years
GnRH Antagonists Produce Differential Modulation of the Signaling Pathways Mediated by GnRH Receptors. (PubMed, Int J Mol Sci)
Although immunostainings suggested that Teverelix could be less effective than Cetrorelix and Ganirelix in inhibiting 1 µM GnRH-induced β-catenin activation, Lhb gene expression increase occurring upon LβT2 cell treatment by 1 µM GnRH was similarly inhibited by all antagonists. To conclude, this study has demonstrated Cetrorelix-, Ganirelix- and Teverelix-specific biased effects at the intracellular level, not affecting the efficacy of antagonists in inhibiting Lhb gene transcription.
Journal
|
CTNNB1 (Catenin (cadherin-associated protein), beta 1)
|
Cetrotide (cetrorelix) • teverelix LA (ARD-03)